Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 2.53 is in line with its 5-year average of 2.40, near the high end of its 5-year range (0.77–2.86).
As of the fiscal period ended Tuesday, June 30, 2026. 8.51% above its 12-month average of 2.33.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.53.
QUICK RATIO (ACID-TEST)
2.53
QUICK RATIO (ACID-TEST) AVG TTM
2.33
QUICK RATIO (ACID-TEST) AVG 3Y
2.42
QUICK RATIO (ACID-TEST) AVG 5Y
2.40
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+8.51%
CURRENT VS 3Y AVG
+4.26%
CURRENT VS 5Y AVG
+5.46%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
-24.55%
vs the sector median at left
Sotera Health Company
Market Cap
$5.20B
Quick Ratio (Acid-Test)
2.53
TTM Avg
2.33
3Y Avg
2.42
5Y Avg
2.40
Market Cap
$5.21B
Quick Ratio (Acid-Test)
3.99
TTM Avg
2.37
3Y Avg
2.88
5Y Avg
3.42
Market Cap
$5.21B
Quick Ratio (Acid-Test)
17.85
TTM Avg
17.70
3Y Avg
17.06
5Y Avg
17.77
Market Cap
$5.19B
Quick Ratio (Acid-Test)
13.57
TTM Avg
9.78
3Y Avg
9.13
5Y Avg
11.38
Market Cap
$5.32B
Quick Ratio (Acid-Test)
3.28
TTM Avg
2.29
3Y Avg
2.05
5Y Avg
2.40
Market Cap
$5.09B
Quick Ratio (Acid-Test)
7.02
TTM Avg
8.28
3Y Avg
8.59
5Y Avg
7.77
Market Cap
$5.07B
Quick Ratio (Acid-Test)
2.79
TTM Avg
2.90
3Y Avg
2.74
5Y Avg
2.21
Market Cap
$5.06B
Quick Ratio (Acid-Test)
1.85
TTM Avg
1.98
3Y Avg
1.97
5Y Avg
1.88
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Sotera Health Company (SHC) | $5.20B | 2.53 | 2.33 | 2.42 | 2.40 |
| Travere Therapeutics, Inc. (TVTX)vs › | $5.21B | 3.99 | 2.37 | 2.88 | 3.42 |
| CRISPR Therapeutics AG (CRSP)vs › | $5.21B | 17.85 | 17.70 | 17.06 | 17.77 |
| Doximity, Inc. (DOCS)vs › | $5.20B | 6.08 | 6.53 | 6.56 | 6.07 |
| Cogent Biosciences, Inc. (COGT)vs › | $5.19B | 13.57 | 9.78 | 9.13 | 11.38 |
| PTC Therapeutics, Inc. (PTCT)vs › | $5.32B | 3.28 | 2.29 | 2.05 | 2.40 |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.09B | 7.02 | 8.28 | 8.59 | 7.77 |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.07B | 2.79 | 2.90 | 2.74 | 2.21 |
| Waystar Holding Corp. (WAY)vs › | $5.06B | 1.85 | 1.98 | 1.97 | 1.88 |
| Erasca, Inc. (ERAS)vs › | $4.96B | 8.29 | 9.94 | 10.32 | 11.01 |
Quick Ratio
2.53
Excludes inventory
Current Ratio
2.80
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 2.53 |
| 2026-03-31 | 2.52 |
| 2025-12-31 | 2.22 |
| 2025-09-30 | 2.16 |
| 2025-06-30 | 2.23 |
| 2025-03-31 | 2.19 |
| 2024-12-31 | 2.50 |
| 2024-09-30 | 2.61 |
| 2024-06-30 | 2.59 |
| 2024-03-31 | 2.86 |
| 2023-12-31 | 2.21 |
| 2023-09-30 | 2.40 |
| 2023-06-30 | 2.52 |
| 2023-03-31 | 1.46 |
| 2022-12-31 | 0.77 |
| 2022-09-30 | 2.74 |
| 2022-06-30 | 2.53 |
| 2022-03-31 | 2.27 |
| 2021-12-31 | 1.81 |
| 2021-09-30 | 2.24 |
| 2021-06-30 | 2.43 |
| 2021-03-31 | 2.14 |
| 2020-12-31 | 2.00 |
| 2020-09-30 | 1.93 |
| 2020-06-30 | 1.84 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 1.73 |
| 2019-09-30 | 0.00 |
| 2019-06-30 | 0.00 |
| 2019-03-31 | 0.00 |
